| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.9 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |